AFAIK RAC isn't going to test bisantrene on prostate cancer.
If you mean the risk that bisantrene might worsen the disease in say breast cancer, that's extremely low because of the historical trials and the preclinicals.
AFAIK RAC isn't going to test bisantrene on prostate...
-
- There are more pages in this discussion • 124 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.66 |
Change
0.025(1.53%) |
Mkt cap ! $282.7M | |||
| Open | High | Low | Value | Volume |
| $1.66 | $1.69 | $1.58 | $350.6K | 215.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | $1.63 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.66 | 2493 | 1 |
View Market Depth
| Last trade - 16.10pm 25/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |